Balofloxacin dihydrate

Cat. No.: OB0225WX-2817

Appearance: Solid

Purity: ≥98%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Balofloxacin dihydrate is an orally bioavailable fluoroquinolone derivative characterized by its broad-spectrum antibiotic activity.

Synonym: Neuroquinoron; 151060-21-8; Balofloxacin (dihydrate); Balofloxacin hydrate; 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxoquinoline-3-carboxylic acid;dihydrate; Neuroquinoron; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)-1-piperidinyl]-4-oxo-, hydrate (1:2); (+/-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)piperidino)-4-oxo-3-quinolinecarboxylic acid, dihydrate; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo-, dihydrate; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo-, dihydrate, (+/-)-; (+/-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)-1-piperidinyl]-4-oxo-3-quinolinecarboxylic acid dihydrate

CAS No.: 151060-21-8

Compound CID: 6918202

Formula: C₂₀H₂₈FN₃O₆

Formula Weight: 425.45

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Balofloxacin dihydrate is employed in microbiology research as a broad-spectrum fluoroquinolone antibiotic to investigate the inhibition of bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and repair.